Follicle size and reproductive hormone profiles during a post-weaning altrenogest treatment in primiparous sows.

This study investigated the endocrine background of follicle size changes during post-weaning altrenogest treatment. altrenogest-treated sows received a 20-mg dosage daily at 8.00 a.m. from Day -1 to Day 14 after weaning. On Day -1, only 3/13 altrenogest-treated sows showed LH pulses compared with 8/8 control sows (P=0.001). On Day 0, control sows showed a typical high frequency-low amplitude LH pattern, indicative for recruitment of oestrogenic follicles. In altrenogest-treated animals on Day 0, half of the sows showed high frequency-high amplitude pulses from 4-5h after weaning. In altrenogest-treated sows, average follicle size increased from 3.1±0.5 mm on Day 0 to 4.4±0.6mm on Day 5, then decreased to 3.7±0.5 mm on Day 7 and stabilised thereafter. FSH and oestradiol (E2) concentrations showed a distinct diurnal pattern; high at 7.00 a.m. and low at 3.00 p.m. E2 concentrations (7.00 a.m.) showed a 2.5-fold increase from Day -1 to Day 2, and subsequently a 2-fold decline to reach a plateau at Day 8. FSH concentrations reached maximum levels by Day 5 and slowly declined afterwards. In conclusion, once-daily administration of altrenogest starting one day before weaning delays the weaning-induced increase in LH pulses. Although FSH and follicle size increase until Day 5 after weaning, follicle E2 production already decreased from Day 2 after weaning. Post-weaning altrenogest treatment thus results in a follicular wave of follicles that lose oestrogenic competence at Day 2 after weaning, presumably related to the changed LH dynamics during altrenogest treatment.

Management factors associated with sow reproductive performance after weaning.

To achieve optimal reproductive performance in pig herds, sows need to become pregnant as soon as possible after weaning. The aim of this study was to investigate herd and management factors associated with reproductive performance of sows after weaning. A questionnaire pertaining to sow management at weaning and herd reproductive data were collected from 76 randomly selected commercial pig herds in Belgium. Associations between the herd factors and two reproductive parameters after weaning (weaning-to-oestrous interval: WEI and percentage of repeat breeders: RB) were analysed using general linear mixed models. A separated feeding strategy of breeding gilts from 60 kg onwards was significantly associated with a shorter WEI (5.54 vs 7.28 days; p = 0.040). Factors significantly associated with a lower percentage of RB were housing the newly weaned sows separated from the gestating sows (7% vs 12%; p = 0.003), using semen < 4 days after collection (7-9 vs 14%; p = 0.014) and stimulating oestrus twice a day (8 vs 11%; p = 0.025). In conclusion, some management practices, such as feeding strategy of breeding gilts, housing conditions of sows, method of oestrous stimulation and storage duration of semen, have an influence on the outcome of reproductive parameters such as weaning-to-oestrous interval and percentage of repeat breeders. These practices can be implemented rather easily by pig producers and may consequently lead to improvements of reproductive performance of sows after weaning.

Progestagen supplementation during early pregnancy does not improve embryo survival in pigs.

Progesterone supplementation during early pregnancy may increase embryo survival in pigs. The current study evaluated whether oral supplementation with an analogue of progesterone, altrenogest (ALT), affects embryo survival. A first experiment evaluated the effect of a daily 20-mg dosage of ALT during days 1-4 or 2-4 after onset of oestrus on embryo survival at day 42 of pregnancy. A control group (CTR1) was not treated. The time of ovulation was estimated by transrectal ultrasound at 12-h intervals. Altrenogest treatment significantly reduced pregnancy rate when start of treatment was before or at ovulation: 25% (5/20) compared to later start of treatment [85% (28/33)] and non-treated CTR1 [100% (23/23)]. Altrenogest treatment also reduced (p < 0.05) number of foetuses, from 14.6 ± 2.6 in CTR1 to 12.5 ± 2.5 when ALT started 1-1.5 days from ovulation and 10.7 ± 2.9 when ALT started 0-0.5 days from ovulation. In a second experiment, sows with a weaning-to-oestrous interval (WOI) of 6, 7 or 8-14 days were given ALT [either 20 mg (ALT20; n = 49) or 10 mg (ALT10; n = 48)] at day 4 and day 6 after onset of oestrus or were not treated (CTR2; n = 49), and farrowing rate and litter size were evaluated. Weaning-to-oestrous interval did not affect farrowing rate or litter size. ALT did not affect farrowing rate (86% vs 90% in CTR2), but ALT20 tended to have a lower litter size compared with CTR2 (11.7 ± 4.1 vs 13.3 ± 3.1; p = 0.07) and ALT10 was intermediate (12.3 ± 2.9). In conclusion, altrenogest supplementation too soon after ovulation reduces fertilization rate and embryo survival rate and altrenogest supplementation at 4-6 days of pregnancy reduces litter size. As a consequence, altrenogest supplementation during early pregnancy may reduce both farrowing rate and litter size and cannot be applied at this stage in practice as a remedy against low litter size.

Incidence and prevention of early parturition in sows.

A retrospective study, based on 60,990 farrowing records from 35 commercial herds, was performed to determine the incidence of early parturition (<114 d) and to investigate the relationship between early parturition and total number of piglets born, number of piglets born alive and percentage of stillborn piglets per litter. The mean gestation length was 115.4 ± 1.62 d, and early parturition occurred in 10% of all farrowing records. Sows with early parturition had significantly more stillborn piglets and a larger litter size compared to sows with a normal gestation length (114-117 d). Sows with a gestation length <114 d were 1.2 times (95% CI: 1.19-1.21; p<0.001) more likely to have an early parturition at the subsequent parity. A second study was performed in four herds (n=329) to investigate the efficacy of altrenogest administration on 110-112 d (T112) or 111-113 d (T113) of gestation for preventing early parturition and to investigate the effect of this treatment on the reproductive performance of sows. The interval between the last altrenogest treatment and the onset of parturition was 3.3 ± 1.32 (T112) or 2.0 ± 0.89 (T113) days. The gestation length of sows of the altrenogest group (T112 + T113) (115.3 ± 1.23 d) was significantly longer compared to gestation length of the non-treated sows (114.7 ± 1.69d) (p<0.01). Altrenogest treatment had no negative effect on the reproductive performances of the sows. In conclusion, the administration of altrenogest in late gestation is an effective and safe method to prevent early parturition and can counteract the reproductive losses because of premature farrowing, which may occur in a substantial part of the farrowing events.

Involvement of tissue inhibition of metalloproteinases-1 in learning and memory in mice.

Tissue inhibitor of metalloproteinases (TIMP-1) is one of the four-member family (TIMPs-1-4) of multifunctional proteins that inhibit matrix metalloproteinases (MMPs). Its expression in the hippocampus is neuronal-activity-dependent and dramatically induced by stimuli leading to long-term potentiation (LTP), suggesting that TIMP-1 is a candidate plasticity protein potentially involved in learning and memory processes. We tested this hypothesis in a hippocampus-dependent task using the new olfactory tubing maze, with mice carrying a null mutation for TIMP-1 (TIMP-1 KO) and mice overexpressing TIMP-1 (TIMP-1 (tg)). The TIMP-1 KO mice were significantly impaired in making correct odor-reward associations when compared with their respective wild type (WT) littermates, while TIMP-1 overexpressing mice performed better than their WT controls. Both genetically modified mice learned the paradigm and the timing of the task, like their respective WTs, and no olfactory dysfunctioning was observed. These data suggest that TIMP-1 is involved in learning and memory processes related to the hippocampus, and support the hypothesis that the MMP/TIMP ratio, and hence MMP activity, modulates neuronal plasticity in normal learning and memory processes, while altered proteolytic activity could impair cognitive functions.

Variability of energy metabolism and nuclear T3-receptors within the skeletal muscle tissue of pigs different with respect to the halothane gene.

Energy metabolism of skeletal muscle tissue of pigs growing from approximately 12 to 18 kg (12 homozygous halothane negative, HH; 16 heterozygotes, Hh; 17 homozygous halothane susceptible, hh) was measured in vivo using 31P nuclear magnetic resonance (NMR) spectroscopy. Data for intracellular pH, phosphocreatine (PCr), phosphomonoesters (PME), and ATP were analyzed by canonical discriminant analysis, an artificial neural network approach, and analysis of variance. Within the hh pigs, two subpopulations could be distinguished before the application of halothane treatment. Some of the hh pigs had a high PME concentration in the biceps femoris muscle (hh(pme+)), whereas others had a low concentration (hh(pme-)) (2.18 +/- .12 for hh(pme+) vs 1.68 +/- .12 mM for hh(pme-), P < .004). The hh(pme+) pigs were statistically different from HH pigs for pH (P < .03), PME (P < .004), and PCr (P < .008) before halothane treatment. The hh(pme-) pigs were not different from the Hh and HH pigs with respect to PME when measured before halothane treatment (P > .05). However, intracellular pH (P < .03) and PCr (P < .008) of the hh(pme-) pigs were different from those of HH pigs (7.15 vs 7.19 for pH and 38.7 vs 35.1 for PCr, respectively). When combining intracellular pH, PME, and PCr within a canonical discriminant analysis, all were measured before halothane treatment, Hh pigs were found to be different from HH pigs (Mahalanobis distance different from zero, P < .02). In a second experiment, growth rate, depth of longissimus muscle, and maximal binding capacity of nuclear T3-receptors of skeletal muscle tissue were different (P < .05, P < .002, and P < .02, respectively) among pigs selected from the same genetic lines. Of the variability in depth of the longissimus muscle, 22% was explained by variability in maximal binding capacity of nuclear T3-receptors. These results, if confirmed with a large number of pigs, might open new possibilities for selection procedures for leanness because, with respect to halothane susceptibility, a shift between genotypic and phenotypic variability was observed.

Transport of pigs different with respect to the halothane gene: stress assessment.

Two transport experiments were carried out with 18 pigs each. These pigs originated from three genetic lines (homozygous halothane-positive and -negative and heterozygotes). Half the pigs were unfed for 12 h before transport. All pigs were transported twice for 2 h. Before and after transport pigs were anesthetized to take blood samples from the jugular vein and biopsies from the biceps femoris. At the same time equipment to measure body temperature and heart rate were attached or detached. Plasma cortisol and beta-endorphin concentrations were measured as well as the glycogen concentration in the muscle sample. Line differences were detected with respect to body temperature (P < .04), heart rate (P < .05), and cortisol (P < .01). The withholding of feed influenced (P < .04) plasma beta-endorphin concentration. Body temperature (P < .02), heart rate (P < .001), cortisol (P < .01), and beta-endorphin (P < .001) were different before and after transport, whereas a training effect of the transport number was observed for heart rate (P < .07) and plasma beta-endorphin (P < .02). No interactions between treatments were observed. The relationship between cortisol and beta-endorphin suggests a nonconcomitant release of ACTH and beta-endorphin.

Efficacy of early Mycoplasma hyopneumoniae vaccination against mixed respiratory disease in older fattening pigs.

The present field study investigated the efficacy of early Mycoplasma hyopneumoniae vaccination in a farrow-to-finish pig herd with respiratory disease late in the fattening period due to combined infections with M hyopneumoniae and viral pathogens. Five hundred and forty piglets were randomly divided into three groups of 180 piglets each: two groups were vaccinated (Stellamune Once) at either 7 (V1) or 21 days of age (V2), and a third group was left non-vaccinated (NV). The three treatment groups were housed in different pens within the same compartment during the nursery period, and were housed in different but identical compartments during the fattening period. The efficacy was evaluated using performance and pneumonia lesions. The average daily weight gain during the fattening period was 19 (V1) and 18 g/day (V2) higher in both vaccinated groups when compared with the NV group. However, the difference was not statistically significant (P>0.05). The prevalence of pneumonia was significantly lower in both vaccinated groups (V1: 71.5 and V2: 67.1 per cent) when compared with the NV group (80.2 per cent) (P<0.05). There were no significant differences between the two vaccination groups. In conclusion, in the present herd with respiratory disease during the second half of the fattening period caused by M hyopneumoniae and viral infections, prevalence of pneumonia lesions were significantly reduced and growth losses numerically (not statistically significant) decreased by both vaccination schedules.

Effects of altrenogest treatments before and after weaning on follicular development, farrowing rate, and litter size in sows.

In a previous study, we showed that follicle size at weaning affects the response of a sow to a short-term altrenogest treatment after weaning. In this study, an attempt was made to prevent the growth of follicles into larger size categories before weaning by using different altrenogest treatments before weaning to improve reproductive performance after postweaning altrenogest treatments. Sows (87 primiparous and 130 multiparous) were assigned to the following treatments: control (no altrenogest treatment; n=59), RU0-20 (20 mg of altrenogest from d -1 to 6; weaning=d 0; n=53), RU40-20 (40 mg of altrenogest from d -3 to 0 and 20 mg of altrenogest from d 1 to 6; n=53), and RU20-20 (20 mg of altrenogest from d -3 to 6; n=52). Follicle size was assessed daily with transabdominal ultrasound. Follicle sizes on d -3 (3.6 ± 0.7 mm) and at weaning (4.0 ± 0.7 mm) were similar for all treatments. Altrenogest-treated sows had larger follicles at the beginning of the follicular phase than did control sows [5.4 ± 0.1 and 3.8 ± 0.2 mm (least squares means), respectively; P < 0.0001] and on d 4 of the follicular phase [8.0 ± 0.1 and 6.7 ± 0.2 mm (least squares means), respectively; P < 0.0001]. Multiparous sows had larger follicles than did primiparous sows at the beginning of the follicular phase [5.3 ± 0.1 and 4.7 ± 0.1 mm (least squares means), respectively; P < 0.01] and on d 4 of the follicular phase [8.0 ± 0.1 and 7.0 ± 0.1 mm (least squares means), respectively; P < 0.0001]. Farrowing rate and litter size (born alive + dead) were not affected by treatment or parity. However, in primiparous sows, when mummies were included in litter size, altrenogest-treated sows had larger litters than did control sows (13.4 ± 0.5 and 11.9 ± 0.7 piglets, respectively; P=0.02). In primiparous control sows, backfat depth at weaning and litter size were positively related (slope of the regression line=0.82; P < 0.05), which was not the case in primiparous sows receiving altrenogest. In conclusion, the different altrenogest treatments before weaning did not prevent the growth of follicles before weaning and similarly affected subsequent follicle development and fertility. In primiparous sows, altrenogest treatment after weaning increased the number of fetuses during pregnancy, but positive effects seemed limited by uterine capacity. Altrenogest treatment after weaning improved litter size in primiparous sows with reduced backfat depth at weaning, which suggests a specific positive effect of a recovery period after weaning in sows with reduced BCS at weaning.

Variation in LH pulsatility during 24h after a postweaning altrenogest treatment in relation to follicle development in primiparous sows.

This study assessed pulsatile release of LH during altrenogest treatment after weaning in primiparous sows and related this to follicle development, estrus and ovulation rate. Weaned sows (n=10) received altrenogest 20mg/day from D-1 to D13 (weaning=D0) at 0800 h. On D13, blood samples were collected every 12 min from 1000 until 1900 h (1st sampling period) and from 2300 h until 0800 h (2nd sampling period). During the 1st sampling period, LH concentrations remained low and no LH pulses were detected in 8/10 sows. During the 2nd sampling period, average and basal LH concentrations (P<0.04) and frequency of pulses (P<0.0001) were higher than during the 1st sampling period. Sows with short vs. long intervals to estrus (<5 days vs. ≥5 days) had higher basal and average LH concentrations during the 2nd sampling period (P≤0.004) and showed more follicular growth during treatment (P=0.007), generating larger follicles at D14 (P=0.005). Sows with high ovulation rate (≥25) displayed more LH pulses in total than sows with low (<25) ovulation rates (P=0.03). In conclusion, this study showed that altrenogest efficiently prevented LH pulsatility during the first bleeding period and that low frequency/high amplitude LH pulses were generally present during the second bleeding period. This variability in LH release in between two altrenogest administrations (24h) may explain why follicular growth progresses to 5mm during altrenogest treatments. LH pulsatility was related to length of the follicular phase and ovulation rate, which signifies its relevance.

The effect of different postweaning altrenogest treatments of primiparous sows on follicular development, pregnancy rates, and litter sizes.

This study investigated follicular development during and after postweaning altrenogest treatment of primiparous sows in relation to subsequent reproductive performance. Primiparous sows (n = 259) were randomly assigned at weaning (d 0) to 1 of 4 groups: control (no altrenogest, n = 71), RU4 (20 mg of altrenogest from d -1 to 2, n = 62), RU8 (20 mg of altrenogest from d -1 to 6, n = 65), or RU15 (20 mg of altrenogest from d -1 to 13, n = 61). Average follicular size (measured by ultrasound) increased during altrenogest treatment and resulted in larger follicles at the start of the follicular phase for RU4, RU8, and RU15 compared with controls (5.3 ± 0.9, 5.5 ± 1.3, 5.1 ± 1.2, and 3.4 ± 0.6 mm, respectively; P < 0.0001). Farrowing rate was greater in RU15 (95%) than in RU8 (76%; P = 0.04). The RU15 group also had more piglets (2 to 3 more piglets total born and born alive; P < 0.05) than the other treatment groups. Follicular development at weaning clearly affected reproductive performance. At weaning, average follicular size: small (<3.5 mm), medium (3.5 to 4.5 mm), or large (≥ 4.5 mm), was associated with farrowing rates of 86, 78, and 48%, respectively (P < 0.001). Sows with large follicles at weaning had low farrowing rates (71%) in RU4, very low farrowing rates (22%) in RU8, but normal farrowing rates in RU15 (83%). In conclusion, this study showed that 15 d of postweaning altrenogest treatment of primiparous sows may allow follicle turnover in sows that had large follicles at weaning and that this was associated with an improved reproductive performance. It also showed that shorter treatment with altrenogest (4 or 8 d) is beneficial for sows with small follicles at weaning, but is not recommendable for sows with large follicles at weaning.